Pharm/Biotech Resources

Outsourcing Guide

Cont. Education

Software/Reports

Training Courses

Web Seminars

Jobs

Buyer's Guide

Home Page

Pharm Patents /
Licensing

Pharm News

Federal Register

Pharm Stocks

FDA Links

FDA Warning Letters

FDA Doc/cGMP

Pharm/Biotech Events

Consultants

Advertiser Info

Newsletter Subscription

Web Links

Suggestions

Site Map
 

 
 

 


Competitive Benchmarking of Patient Compliance, Adherence and Persistence (CAP) Strategies at Leading Pharmaceutical Companies in the United States
 

This new program provides comprehensive information regarding the initiatives of leading pharmaceutical companies in the United States -- for the purpose of improving patient compliance, adherence and persistence.

The study is the perfect tool for managers who realize the importance of creating "successful" CAP strategies.

For each target company, the study examines:

bullet Key personnel dedicated to patient compliance initiatives
bullet Organizational structure of patient compliance and links to key departments
bullet Key roles by type of personnel
bullet Internal processes for development of patient compliance materials
bullet Detailed description of each major patient compliance initiative/material
bullet And much more!

A companion study is also available that analyzes patient and healthcare providers' perceptions of CAP materials. 

This one-of-a-kind report captures the responses of over 100 practicing oncologists in the United States – as they are asked to rate the effectiveness of leading oncology sales forces in regard to the following attributes:
 

bulletProduct knowledge
bulletDisease-state knowledge
bulletCompetitor product knowledge
bulletSampling frequency
bulletResponsiveness to the needs of the doctor’s practice
bulletCall frequency
bulletTrustworthiness
bulletAnd other pertinent areas…

We not only capture the revealing survey results, but PharmaForce digs deeper by conducting targeted interviews with members of the “best” and “worst” performing sales forces to uncover the reasons for their rankings.

This program analyzes in detail the marketing expenditures of leading oncology franchises in the top five countries in Europe (i.e., France, Germany, Italy, Spain and the United Kingdom).  The key expenditures benchmarked include:

bullet Major conventions
bullet Representative-initiated physician education programs  
bullet Clinical trials for approved products
bullet Advocacy/cooperative group grants
bullet CME programs
bullet Journal advertisements
bullet Printed sales materials

 
Analysis of the sales and marketing organizations includes:

bullet Size and structure of the oncology sales force
bullet How the oncology product portfolio is managed
bullet Organizational structure of oncology sales and marketing management
bullet Deployment of other oncology-related field personnel, such as medical liaisons
bullet Role of oncology medical liaisons
bullet Qualifications and compensation of oncology sales personnel, including typical salary/bonus ratios
 

* Save 5% -- Mention "PharmCast.com" when purchase.

To receive more information about the study, please click on the following "Request for Info" link.

                                       

 

 
 
 
 
[ Outsourcing Guide ] [ Cont. Education ] [ Software/Reports ] [ Training Courses ]
[ Web Seminars ] [ Jobs ] [ Consultants ] [ Buyer's Guide ] [ Advertiser Info ]

[ Home ] [ Pharm Patents / Licensing ] [ Pharm News ] [ Federal Register ]
[ Pharm Stocks ] [ FDA Links ] [ FDA Warning Letters ] [ FDA Doc/cGMP ]
[ Pharm/Biotech Events ] [ Newsletter Subscription ] [ Web Links ] [ Suggestions ]
[ Site Map ]